GlobalData on MSN11h
“No magic wand” for Novo Nordisk, as CagriSema pen supply rumours swirlNovo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.
Novo Nordisk’s (NVO) (OTCPK:NONOF) contract with Swiss medical device maker Ypsomed (OTCPK:YPHDF) includes a deal to supply ...
Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish drugmaker's next-generation experimental obesity drug CagriSema, a source ...
Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish ...
Elon Musk's Neuralink said on Wednesday it has received approval to launch its first clinical trial in Canada for a device ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback